748 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Acquired by Curio Wealth LLC

Curio Wealth LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 748 shares of the exchange traded fund’s stock, valued at approximately $67,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Signaturefd LLC boosted its holdings in SPDR S&P Biotech ETF by 34.4% in the 4th quarter. Signaturefd LLC now owns 2,334 shares of the exchange traded fund’s stock valued at $210,000 after purchasing an additional 598 shares during the period. Parallel Advisors LLC boosted its holdings in SPDR S&P Biotech ETF by 3.8% in the 4th quarter. Parallel Advisors LLC now owns 42,574 shares of the exchange traded fund’s stock valued at $3,834,000 after purchasing an additional 1,568 shares during the period. Ascent Capital Management LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $444,000. Family Firm Inc. boosted its holdings in SPDR S&P Biotech ETF by 3.7% in the 4th quarter. Family Firm Inc. now owns 6,797 shares of the exchange traded fund’s stock valued at $612,000 after purchasing an additional 243 shares during the period. Finally, United Capital Management of KS Inc. boosted its holdings in SPDR S&P Biotech ETF by 1.5% in the 4th quarter. United Capital Management of KS Inc. now owns 173,115 shares of the exchange traded fund’s stock valued at $15,591,000 after purchasing an additional 2,588 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $87.13 on Monday. The firm has a fifty day moving average price of $90.06 and a two-hundred day moving average price of $94.78. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The company has a market cap of $5.65 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.